Recombinant multi-species MYH1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MYH1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Myosin is a major contractile protein which converts chemical energy into mechanical energy through the hydrolysis of ATP. Myosin is a hexameric protein composed of a pair of myosin heavy chains (MYH) and two pairs of nonidentical light chains. Myosin heavy chains are encoded by a multigene family. In mammals at least 10 different myosin heavy chain (MYH) isoforms have been described from striated, smooth, and nonmuscle cells. These isoforms show expression that is spatially and temporally regulated during development. [provided by RefSeq, Jul 2008]
The Alternative Names of target: A530084A17Rik,HEL71,IId,IId/x,MHC-2X/D,MHC2X/D,MYH1,MYHC,MYHC-2X,MYHC-2d,MYHC-IIX,MYHSA1,MYHa,MdMs,MyHC-2X/D,MyHC-2x,MyHC-IId/x,MyHC-IIx/d,Myh1,Myhs-f,Myhs-f2,Myhsf2,Myosin heavy chain,Myosin heavy chain 1,Myosin heavy chain 2x (MyHC-2x),Myosin heavy chain IIx/d (MyHC-IIx/d),Myosin-1,adult 1,skeletal muscle

Target products collectionGo to MYH1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9010-Ag-1/ GM-Tg-hg-IP9010-Ag-2 Human MYH1 protein Human
GM-Tg-rg-IP9010-Ag-1/ GM-Tg-rg-IP9010-Ag-2 Rat MYH1 protein Rat
GM-Tg-mg-IP9010-Ag-1/ GM-Tg-mg-IP9010-Ag-2 Mouse MYH1 protein Mouse
GM-Tg-cynog-IP9010-Ag-1/ GM-Tg-cynog-IP9010-Ag-2 Cynomolgus/Rhesus macaque MYH1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9010-Ag-1/ GM-Tg-felg-IP9010-Ag-2 Feline MYH1 protein Feline
GM-Tg-cang-IP9010-Ag-1/ GM-Tg-cang-IP9010-Ag-2 Canine MYH1 protein Canine
GM-Tg-bovg-IP9010-Ag-1/ GM-Tg-bovg-IP9010-Ag-2 Bovine MYH1 protein Bovine
GM-Tg-equg-IP9010-Ag-1/ GM-Tg-equg-IP9010-Ag-2 Equine MYH1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9010-Ag-1/ GM-Tg-hg-IP9010-Ag-2; GM-Tg-rg-IP9010-Ag-1/ GM-Tg-rg-IP9010-Ag-2;
GM-Tg-mg-IP9010-Ag-1/ GM-Tg-mg-IP9010-Ag-2; GM-Tg-cynog-IP9010-Ag-1/ GM-Tg-cynog-IP9010-Ag-2;
GM-Tg-felg-IP9010-Ag-1/ GM-Tg-felg-IP9010-Ag-2; GM-Tg-cang-IP9010-Ag-1/ GM-Tg-cang-IP9010-Ag-2;
GM-Tg-bovg-IP9010-Ag-1/ GM-Tg-bovg-IP9010-Ag-2; GM-Tg-equg-IP9010-Ag-1/ GM-Tg-equg-IP9010-Ag-2
Products Name MYH1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MYH1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MYH1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.